SK287396B6 - Použitie mirtazapínu na liečenie porúch spánku - Google Patents

Použitie mirtazapínu na liečenie porúch spánku Download PDF

Info

Publication number
SK287396B6
SK287396B6 SK1144-2002A SK11442002A SK287396B6 SK 287396 B6 SK287396 B6 SK 287396B6 SK 11442002 A SK11442002 A SK 11442002A SK 287396 B6 SK287396 B6 SK 287396B6
Authority
SK
Slovakia
Prior art keywords
mirtazapine
treatment
sleep
sleep disorders
dose
Prior art date
Application number
SK1144-2002A
Other languages
English (en)
Slovak (sk)
Other versions
SK11442002A3 (sk
Inventor
Gerardus Stephanus Franciscus Ruigt
Den Berg Frans Van
Original Assignee
N.V. Organon
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by N.V. Organon filed Critical N.V. Organon
Publication of SK11442002A3 publication Critical patent/SK11442002A3/sk
Publication of SK287396B6 publication Critical patent/SK287396B6/sk

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Neurosurgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Anesthesiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
SK1144-2002A 2000-02-11 2001-02-06 Použitie mirtazapínu na liečenie porúch spánku SK287396B6 (sk)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP00200499 2000-02-11
PCT/EP2001/001221 WO2001058453A1 (en) 2000-02-11 2001-02-06 The use of mirtazapine for the treatment of sleep disorders

Publications (2)

Publication Number Publication Date
SK11442002A3 SK11442002A3 (sk) 2003-02-04
SK287396B6 true SK287396B6 (sk) 2010-08-09

Family

ID=8171013

Family Applications (1)

Application Number Title Priority Date Filing Date
SK1144-2002A SK287396B6 (sk) 2000-02-11 2001-02-06 Použitie mirtazapínu na liečenie porúch spánku

Country Status (25)

Country Link
US (1) US6933293B2 (no)
EP (4) EP1656937A1 (no)
JP (1) JP5039994B2 (no)
KR (1) KR20020069371A (no)
CN (2) CN101229170A (no)
AR (1) AR027394A1 (no)
AT (1) ATE317261T1 (no)
AU (1) AU780439B2 (no)
BR (1) BR0108261A (no)
CA (1) CA2396209C (no)
CO (1) CO5271706A1 (no)
CZ (1) CZ302368B6 (no)
DE (1) DE60117122T2 (no)
DK (1) DK1257278T3 (no)
ES (1) ES2258071T3 (no)
HK (1) HK1049122B (no)
HU (1) HUP0204391A3 (no)
IL (2) IL150290A0 (no)
NO (1) NO328007B1 (no)
PE (1) PE20011080A1 (no)
PL (1) PL206073B1 (no)
RU (1) RU2270680C2 (no)
SK (1) SK287396B6 (no)
WO (1) WO2001058453A1 (no)
ZA (1) ZA200205238B (no)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040152055A1 (en) * 2003-01-30 2004-08-05 Gliessner Michael J.G. Video based language learning system
UA83666C2 (ru) 2003-07-10 2008-08-11 Н.В. Органон Способ получения энантиомерно чистого миртазапина
WO2005051349A2 (en) * 2003-11-25 2005-06-09 Aurobindo Pharma Ltd. Pharmaceutical compositions of mirtazapine
GB0417558D0 (en) * 2004-08-06 2004-09-08 Merck Sharp & Dohme Novel combination therapy
EP1806133A1 (en) * 2004-10-14 2007-07-11 Daikin Industries, Ltd. Method for modifying the ambience, and spray liquid and sprayer used in the method
JP2006137748A (ja) * 2004-10-14 2006-06-01 Daikin Ind Ltd 雰囲気改変方法、並びに、それに用いられる噴霧剤及び噴霧装置
JP2007284363A (ja) * 2006-04-13 2007-11-01 Daikin Ind Ltd 噴霧剤
CN101679431B (zh) 2007-04-11 2013-08-14 Msd欧斯股份有限公司 制备四环苯并氮杂卓的对映异构体的方法
US10603272B2 (en) 2015-02-27 2020-03-31 Kindred Biosciences, Inc. Stimulation of appetite and treatment of anorexia in dogs and cats
CN111053735A (zh) * 2020-02-25 2020-04-24 上海阶平医院管理有限公司 一种治疗失眠的冷敷凝胶

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL189199C (nl) 1975-04-05 1993-02-01 Akzo Nv Werkwijze ter bereiding van farmaceutische preparaten met werking op het centraal zenuwstelsel op basis van benz(aryl)azepinederivaten, de verkregen gevormde farmaceutische preparaten, alsmede werkwijze ter bereiding van de toe te passen benz(aryl)azepinederivaten.
EP0813873B1 (en) * 1996-06-19 2002-02-13 Akzo Nobel N.V. Pharmaceutical composition comprising mirtazapine and one or more selective serotonin reuptake inhibitors
WO1999025356A1 (en) * 1997-11-14 1999-05-27 Akzo Nobel N.V. Use of mirtazapine for treating sleep apneas

Also Published As

Publication number Publication date
CZ20022330A3 (cs) 2002-11-13
KR20020069371A (ko) 2002-08-30
NO20023803D0 (no) 2002-08-09
HK1049122A1 (en) 2003-05-02
RU2270680C2 (ru) 2006-02-27
CZ302368B6 (cs) 2011-04-13
NO328007B1 (no) 2009-11-09
WO2001058453A1 (en) 2001-08-16
JP2003522147A (ja) 2003-07-22
CN101229170A (zh) 2008-07-30
PL206073B1 (pl) 2010-06-30
AR027394A1 (es) 2003-03-26
AU780439B2 (en) 2005-03-24
EP1658850A1 (en) 2006-05-24
CN1395487A (zh) 2003-02-05
PL356721A1 (en) 2004-06-28
JP5039994B2 (ja) 2012-10-03
DE60117122D1 (de) 2006-04-20
EP1257278A1 (en) 2002-11-20
IL150290A (en) 2010-12-30
PE20011080A1 (es) 2001-10-18
ZA200205238B (en) 2003-09-29
EP2283840A1 (en) 2011-02-16
BR0108261A (pt) 2003-03-05
RU2002124141A (ru) 2004-03-10
EP1656937A1 (en) 2006-05-17
AU3024701A (en) 2001-08-20
ES2258071T3 (es) 2006-08-16
CO5271706A1 (es) 2003-04-30
HK1049122B (zh) 2006-04-21
EP1257278B1 (en) 2006-02-08
NO20023803L (no) 2002-10-09
SK11442002A3 (sk) 2003-02-04
ATE317261T1 (de) 2006-02-15
IL150290A0 (en) 2002-12-01
DK1257278T3 (da) 2006-06-12
US6933293B2 (en) 2005-08-23
HUP0204391A3 (en) 2005-03-29
HUP0204391A2 (en) 2003-05-28
DE60117122T2 (de) 2006-07-27
CA2396209C (en) 2009-09-01
US20030022888A1 (en) 2003-01-30
CA2396209A1 (en) 2001-08-16

Similar Documents

Publication Publication Date Title
EP1001760B1 (en) Composition for controlling mood disorders in healthy individuals
US20130150434A1 (en) Methods of using low-dose doxepin for the improvement of sleep
NZ196048A (en) Anti-depressant compositions with reduced induction of drowsiness-benzodiazepine tranquilliser/m-(chloro or fluoro)-t-butylaminopropiophenone
RU2268725C2 (ru) Комбинация лекарственных препаратов, включающая миртазапин, для лечения депрессии и связанных расстройств
SK287396B6 (sk) Použitie mirtazapínu na liečenie porúch spánku
JPH0667842B2 (ja) 基本的うつ病を軽減するためのうつ病治療剤
US9308212B2 (en) Compositions comprising alprazolam for treating primary insomnia and insomnia associated with anxiety states and process for preparing them
KR100692235B1 (ko) 안지오텐신 ⅱ 길항물질의 신규한 용도
MOK et al. Multidose/observational, comparative clinical analgetic evaluation of buprenorphine
EP1425026B1 (en) Valeriana officinalis extract for treating sleep-induced apnea or hypopnea
MXPA02006710A (en) The use of mirtazapine for the treatment of sleep disorders
OA16802A (en) Pharmaceutical composition for treating premature ejaculation and method for treating premature ejaculation.
WO2013152108A1 (en) 5ht1a agonist for treatment of high cholesterol

Legal Events

Date Code Title Description
MM4A Patent lapsed due to non-payment of maintenance fees

Effective date: 20120206